These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

364 related items for PubMed ID: 25107427

  • 41. Differences in crystallization rate of nitrendipine enantiomers in amorphous solid dispersions with HPMC and HPMCP.
    Miyazaki T, Aso Y, Yoshioka S, Kawanishi T.
    Int J Pharm; 2011 Apr 04; 407(1-2):111-8. PubMed ID: 21277962
    [Abstract] [Full Text] [Related]

  • 42. Moisture sorption by polymeric excipients commonly used in amorphous solid dispersion and its effect on glass transition temperature: I. Polyvinylpyrrolidone and related copolymers.
    Patel NG, Serajuddin ATM.
    Int J Pharm; 2022 Mar 25; 616():121532. PubMed ID: 35121046
    [Abstract] [Full Text] [Related]

  • 43. Role of the Strength of Drug-Polymer Interactions on the Molecular Mobility and Crystallization Inhibition in Ketoconazole Solid Dispersions.
    Mistry P, Mohapatra S, Gopinath T, Vogt FG, Suryanarayanan R.
    Mol Pharm; 2015 Sep 08; 12(9):3339-50. PubMed ID: 26070543
    [Abstract] [Full Text] [Related]

  • 44. Initial Drug Dissolution from Amorphous Solid Dispersions Controlled by Polymer Dissolution and Drug-Polymer Interaction.
    Chen Y, Wang S, Wang S, Liu C, Su C, Hageman M, Hussain M, Haskell R, Stefanski K, Qian F.
    Pharm Res; 2016 Oct 08; 33(10):2445-58. PubMed ID: 27283830
    [Abstract] [Full Text] [Related]

  • 45. Effect of cations and anions on glass transition temperatures in excipient solutions.
    Nesarikar VV, Nassar MN.
    Pharm Dev Technol; 2007 Oct 08; 12(3):259-64. PubMed ID: 17613889
    [Abstract] [Full Text] [Related]

  • 46. Impact of Drug-Polymer Miscibility on Enthalpy Relaxation of Irbesartan Amorphous Solid Dispersions.
    Dalsania S, Sharma J, Munjal B, Bansal AK.
    Pharm Res; 2018 Jan 09; 35(2):29. PubMed ID: 29368174
    [Abstract] [Full Text] [Related]

  • 47. Phase behavior of poly(vinylpyrrolidone) containing amorphous solid dispersions in the presence of moisture.
    Rumondor AC, Marsac PJ, Stanford LA, Taylor LS.
    Mol Pharm; 2009 Jan 09; 6(5):1492-505. PubMed ID: 19634917
    [Abstract] [Full Text] [Related]

  • 48. Estimation of the fragility index of indomethacin by DSC using the heating and cooling rate dependency of the glass transition.
    Ramos JJ, Taveira-Marques R, Diogo HP.
    J Pharm Sci; 2004 Jun 09; 93(6):1503-7. PubMed ID: 15124208
    [Abstract] [Full Text] [Related]

  • 49. Solubilities of crystalline drugs in polymers: an improved analytical method and comparison of solubilities of indomethacin and nifedipine in PVP, PVP/VA, and PVAc.
    Sun Y, Tao J, Zhang GG, Yu L.
    J Pharm Sci; 2010 Sep 09; 99(9):4023-31. PubMed ID: 20607809
    [Abstract] [Full Text] [Related]

  • 50. Development of fully amorphous dispersions of a low T(g) drug via co-spray drying with hydrophilic polymers.
    Zhao M, Barker SA, Belton PS, McGregor C, Craig DQ.
    Eur J Pharm Biopharm; 2012 Nov 09; 82(3):572-9. PubMed ID: 22922419
    [Abstract] [Full Text] [Related]

  • 51. An investigation into the role of polymeric carriers on crystal growth within amorphous solid dispersion systems.
    Tian Y, Jones DS, Andrews GP.
    Mol Pharm; 2015 Apr 06; 12(4):1180-92. PubMed ID: 25692314
    [Abstract] [Full Text] [Related]

  • 52. Physical aging of hydroxypropyl methylcellulose acetate succinate via enthalpy recovery.
    Seo Y, Zuo B, Cangialosi D, Priestley RD.
    Soft Matter; 2022 Nov 09; 18(43):8331-8341. PubMed ID: 36300535
    [Abstract] [Full Text] [Related]

  • 53. Molecular Factors Governing the Liquid and Glassy States Recrystallization of Celecoxib in Binary Mixtures with Excipients of Different Molecular Weights.
    Grzybowska K, Chmiel K, Knapik-Kowalczuk J, Grzybowski A, Jurkiewicz K, Paluch M.
    Mol Pharm; 2017 Apr 03; 14(4):1154-1168. PubMed ID: 28241116
    [Abstract] [Full Text] [Related]

  • 54. Long-Term Physical Stability of PVP- and PVPVA-Amorphous Solid Dispersions.
    Lehmkemper K, Kyeremateng SO, Heinzerling O, Degenhardt M, Sadowski G.
    Mol Pharm; 2017 Jan 03; 14(1):157-171. PubMed ID: 28043133
    [Abstract] [Full Text] [Related]

  • 55. Effects of polymer type and storage relative humidity on the kinetics of felodipine crystallization from amorphous solid dispersions.
    Rumondor AC, Stanford LA, Taylor LS.
    Pharm Res; 2009 Dec 03; 26(12):2599-606. PubMed ID: 19806435
    [Abstract] [Full Text] [Related]

  • 56. Phase behaviour analysis of solid dispersions of loperamide and two structurally related compounds with the polymers PVP-K30 and PVP-VA64.
    Weuts I, Kempen D, Decorte A, Verreck G, Peeters J, Brewster M, Van den Mooter G.
    Eur J Pharm Sci; 2004 Aug 03; 22(5):375-85. PubMed ID: 15265507
    [Abstract] [Full Text] [Related]

  • 57. Controlling the Release of Indomethacin from Glass Solutions Layered with a Rate Controlling Membrane Using Fluid-Bed Processing. Part 2: The Influence of Formulation Parameters on Drug Release.
    Dereymaker A, Pelgrims J, Engelen F, Adriaensens P, Van den Mooter G.
    Mol Pharm; 2017 Apr 03; 14(4):974-983. PubMed ID: 28207272
    [Abstract] [Full Text] [Related]

  • 58. Selection of excipient, solvent and packaging to optimize the performance of spray-dried formulations: case example fenofibrate.
    Hugo M, Kunath K, Dressman J.
    Drug Dev Ind Pharm; 2013 Feb 03; 39(2):402-12. PubMed ID: 22591213
    [Abstract] [Full Text] [Related]

  • 59. Physical stabilisation of amorphous ketoconazole in solid dispersions with polyvinylpyrrolidone K25.
    Van den Mooter G, Wuyts M, Blaton N, Busson R, Grobet P, Augustijns P, Kinget R.
    Eur J Pharm Sci; 2001 Jan 03; 12(3):261-9. PubMed ID: 11113645
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.